CPHI & PMEC China 2026
06/2026 – 06/2026
회사 소개
- 법인명: JIANGSU GTIG HUATAI CO.,LTD
- 등록 국가: China
- 주소: 15-16/F., Huachang Oriental Plaza, Renmin Road, Zhangjiagang City
- 직원 수: 50 - 99
설명:
Jiangsu GTIG Huatai Co., Ltd. is one of China's top 500 companies, specializing in intermediates and APIs for Sofosbuvir, Ledipasvir, Velpatasvir, Venetoclax, Obeticholic Acid, Palbociclib, Glecaprevir, Dolutegravir, Alectinib, Eribulin Mesylate, Bictegravir, Niraparib, Ribociclib, Dabigatran etexilate mesylate, Sacubitril, Vilanterol, Umeclidinium Bromide, Indacaterol, Ibrutinib, Baricitinib and Pazopanib, among others, with any patent-related products supplied for research purposes only.
사업 활동
천연추출물 & 생약원료
유통업체
제약용 화학물질
유통업체
ATC 분류체계 (해부치료화학분류)
유통업체
오리지널 원료의약품
유통업체
판매 시장
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria, Czech Republic
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
당사 제품 & 서비스
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
증거
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기